Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-044054

Chief Executive Officer sold 3,000 shares at $51.18 ($153,540)

  • Chief Executive Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-07-03 Option exercise +3,000 $0.30 $908 3,000 D
Schenkein David P Chief Executive Officer 2017-07-03 Sale −3,000 $51.18 $153,540 0 D
Derivatives
Schenkein David P Chief Executive Officer 2017-07-03 Option exercise · Stock option (right to buy) −3,000 186,656 D
Open-market sales · 3,000 sh · avg $51.18 · $153,540
Loading xslF345X03/doc4.xml…